SOLICITATION NOTICE
A -- Food and Drug Administration Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science - Amendment 1
- Notice Date
- 1/17/2020 8:58:08 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 5417
— Scientific Research and Development ServicesT
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS ROCKVILLE MD 20857 USA
- ZIP Code
- 20857
- Solicitation Number
- FDABAA-20-00123
- Response Due
- 3/2/2020 2:00:00 PM
- Archive Date
- 10/01/2020
- Point of Contact
- Christine Russman, Phone: 3017967841, Richard Robinson, Phone: 301-796-6508
- E-Mail Address
-
Christine.Russman@fda.hhs.gov, Richard.Robinson@fda.hhs.gov
(Christine.Russman@fda.hhs.gov, Richard.Robinson@fda.hhs.gov)
- Description
- Amendment 1 The purpose of this amendment is to: provide the FDA's updated research areas of interest; provide�additional information regarding proposal instructions; and, change the White Paper due date from March 13, 2020, to March 2, 2020. Please see the attached document entitled FDABAA-20-00123 - Amendment 1 for the most current version of the FDA's Broad Agency Announcement. Original Description The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.� *This announcement is a renewal of the FY19 announcement (FDABAA-19-00123) and will remain open until further notice.� It is renewed on an annual basis.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/1c2db86ed5b2440a9ef5b4fc2d5a5c09/view)
- Record
- SN05538001-F 20200119/200117230134 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |